Pilot study: bone marrow stem cells as a treatment for dogs with chronic spinal cord injury

Webb AA, Ngan S, Fowler JD: Spinal cord injury I: a synopsis of the basic science. Can Vet J-Rev 2010, 51: 485–492. Mothe AJ, Tator CH: Advances in stem cell therapy for spinal cord injury. J Clin Invest 2012, 122: 3824–3834. 10.1172/JCI64124 Antonic A, Sena ES, Lees JS, Wills TE, Skeers P, Batchelor PE, Macleod MR, Howells DW: Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies. PLoS Biol 2013, 11: e1001738. doi:10.1371/journal.pbio.1001738 10.1371/journal.pbio.1001738 McKee WM: Spinal trauma in dogs and cats: a review of 51 cases. Vet Rec 1990, 126: 285–289. Bruce CW, Brisson BA, Gyselinck K: Spinal fracture and luxation in dogs and cats; a retrospective evaluation of 95 cases. Vet Comp Orthop Traumatol 2008, 21: 280–284. Olson L: Medicine: clearing a path for nerve growth. Nature 2002, 416: 589–590. 10.1038/416589a Jeffery ND, Lakatos A, Franklin RJM: Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury. J Neurotrauma 2005, 22: 1282–1293. 10.1089/neu.2005.22.1282 Penning V, Platt SR, Dennis R, Capello R, Adams V: Association of spinal cord compression seen on magnetic resonance imaging with clinical outcome in 67 dogs with thoracolumbar intervertebral disc extrusion. J Small Anim Pract 2006, 47: 644–655. 10.1111/j.1748-5827.2006.00252.x Olby NJ, Risio LD, Muñana KR, Wosar MA, Skeen TM, Sharp NJH, Keene BW: Development of a functional scoring system in dogs with acute spinal cord injuries. Am J Vet Res 2001, 62: 1624–1628. 10.2460/ajvr.2001.62.1624 Levine GJ, Levine JM, Budke CM, Kerwin SC, Au J, Vinayak A, Hettlich BF, Slater MR: Description and repeatability of a newly developed spinal cord injury scale for dogs. Prev Vet Med 2009, 89: 121–127. 10.1016/j.prevetmed.2009.02.016 Srugo I, Aroch I, Christopher MM, Chai O, Goralnik L, Bdolah-Abram T, Shamir MH: Signs and outcome in acute nonambulatory thoracolumbar disc disease in dogs. J Vet Intern Med 2011, 25: 846–855. 10.1111/j.1939-1676.2011.0739.x Henke D, Vandevelde M, Doherr MG, Stockli M, Forterre F: Correlations between severity of clinical signs and histopathological changes in 60 dogs with spinal cord injury associated with acute thoracolumbar intervertebral disc desease. Vet J 2013, 198: 70–75. 10.1016/j.tvjl.2013.04.003 Mackay-Sim A, Feron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W, Fronek P, Gray C, Kerr G, Licina P, Nowitzke A, Perry C, Silburn PAS, Urquhart S, Geraghty T: Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 2008, 131: 2376–2386. 10.1093/brain/awn173 Kumar AA, Kumar SR, Narayanan R, Arul K, Baskaran M: Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data. Exp Clin Transplant 2009, 7: 241–248. Attar A, Ayten M, Ozdemir M, Ozgencil E, Bozkurt M, Kaptanoglu E, Beksac M, Kanpolat Y: An attempt to treat patients who have injured spinal cords with intralesional implantation of concentrated autologous bone marrow cells. Cytotherapy 2011, 13: 54–60. 10.3109/14653249.2010.510506 Park HC, Shim YS, Yoon SH, Park SR, Choi BH, Park HS: Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 2005, 11: 913–922. 10.1089/ten.2005.11.913 Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, Kocsis JD: Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res 2010, 1343: 226–235. Hawryluk GW, Mothe A, Wang J, Wang S, Tator C, Fehlings MG: An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev 2012, 21: 2222–2238. 10.1089/scd.2011.0596 Eun-Sun K, Kee-Yong H, Young-Hoon KJ: Fate of transplanted bone marrow derived mesenchymal stem cells following spinal cord injury in rats by transplantation routes. J Korean Med Sci 2012, 27: 586–593. 10.3346/jkms.2012.27.6.586 Deng YB, Yuan QT, Liu XG, Liu XL, Liu Y, Liu ZG, Zhang C: Functional recovery after rhesus monkey spinal cord injury by transplantation of bone marrow mesenchymal-stem cell-derived neurons. Chin Med J 2005, 118: 1533–1541. Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, Dixit A, Rauthan A, Murgod U, Totey S: Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy 2009, 11: 897–911. 10.3109/14653240903253857 Jung DI, Ha J, Kang BT, Kim JW, Quan FS, Lee JH, Woo EJ, Park HM: A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. J Neurol Sci 2009, 285: 67–77. 10.1016/j.jns.2009.05.027 Nishida H, Nakayama M, Tanaka H, Kitamura M, Hatoya S, Sugiura K, Suzuki Y, Ide C, Inaba T: Evaluation of transplantation of autologous bone marrow stromal cells into the cerebrospinal fluid for treatment of chronic spinal cord injury in dogs. Am J Vet Res 2011, 72: 1118–1123. 10.2460/ajvr.72.8.1118 Fawcett JW, Curt A, Steeves JD: Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007, 45: 190–205. 10.1038/sj.sc.3102007 William JB, Prabakaran R, Ayyappan S, Puskhinraj H, Rao D, Thamaraikannan P, Dedeepiya VD, Kuroda S, Yoshioka H, Mori Y, Preethy S, Abraham SJK: Functional recovery of spinal cord injury following application of intralesional bone marrow mononuclear cells embedded in polymer scaffold - two year follow-up in a canine. J Stem Cell Res Ther 2011, 1: 110. Kroger N, Zabelina T, Renges H, Kruger W, Kordes U, Rischewski J, Schrum J, Horstmann M, Ayuk F, Erttmann R, Kabisch H, Zander AR: Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin. Ann Hematol 2002, 81: 627–631. 10.1007/s00277-002-0566-0 Park JH, Kim DY, Sung IY, Choi GH, Jeon MH, Kim KK, Jeon SR: Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery 2012, 70: 1238–1247. 10.1227/NEU.0b013e31824387f9 Deda H, Inci MC, Kürekçi AE, Kayihan K, Ozgün E, Ustünsoy GE, Kocabay S: Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 2008, 10: 565–574. 10.1080/14653240802241797 Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD, Crain B: Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A 2003, 100: 1364–1369. 10.1073/pnas.0336479100 Krause DS: Plasticity of marrow-derived stem cells. Gene Ther 2002, 9: 754–758. 10.1038/sj.gt.3301760 Wenceslau CV, Miglino MA, Martins DS, Ambrósio CE, Lizier NF, Pignatari GC, Kerkis I: Mesenchymal progenitor cells from canine fetal tissues: yolk sac, liver, and bone marrow. Tissue Eng 2011, 17: 2165–2176. 10.1089/ten.tea.2010.0678 Strom TB, Field LJ, Ruediger M: Allogeneic stem cells, clinical transplantation and the origins of regenerative medicine. Curr Opin Immunol 2002, 14: 601–605. 10.1016/S0952-7915(02)00387-4 Erdo F, Buhrle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, Focking M, Kustermann E, Kolossov E, Hescheler J, Hossmann KA, Trapp T: Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 2003, 23: 780–785.